Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis
Clinical trial NCT06142357 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06142357
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-29
- Primary completion
- 2027-08-31
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.